Your session is about to expire
← Back to Search
Behavioral Intervention
Online Physical Activity Intervention for Multiple Sclerosis (eHAPA-MS Trial)
N/A
Recruiting
Led By Chungyi Chiu, PhD
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants are 18 years old and above
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 month
Awards & highlights
eHAPA-MS Trial Summary
This trial will test an online intervention to get people with MS to be more physically active. They will assess how well it works and how well people stick to it.
Who is the study for?
This trial is for adults over 18 with Multiple Sclerosis who haven't had a relapse in the last 30 days. They should be able to walk (with or without help), not currently active (less than 30 minutes of moderate physical activity on most days), and have safe levels for exercise. Participants need internet access, as they'll complete online surveys and wear an activity tracker.Check my eligibility
What is being tested?
The study tests an online program called eHAPA-MS designed to encourage physical activity among people with Multiple Sclerosis. It's based on the Health Action Process Approach, which focuses on personal motivation and planning. Participants will either receive this intervention or be placed in a control group by chance.See study design
What are the potential side effects?
Since this trial involves an online educational program rather than medication, traditional side effects are not expected. However, participants may experience discomfort from increased physical activity if they're not used to it.
eHAPA-MS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
eHAPA-MS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
The Health Action Process Approach Battery
eHAPA-MS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: MSPA eClassExperimental Treatment1 Intervention
Group II: Waiting listActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
37,275 Total Patients Enrolled
15 Trials studying Multiple Sclerosis
625 Patients Enrolled for Multiple Sclerosis
Chungyi Chiu, PhDPrincipal InvestigatorUniversity of Illinois Urbana-Champaign
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can walk by myself or with help from a device.I can walk by myself or with help like a cane or walker.I am 18 years old or older.I have not had a relapse in the last 30 days.They can access the Internet.I am willing to be assigned to a study group, fill out surveys, and wear an activity tracker.You haven't been active for 30 minutes a day, 2 days a week, for the past 6 months.You have a low score on the Godin Leisure-Time Exercise Questionnaire.You can participate if you answer "yes" to no more than one question on the Physical Activity Readiness Questionnaire.
Research Study Groups:
This trial has the following groups:- Group 1: MSPA eClass
- Group 2: Waiting list
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Multiple Sclerosis Patient Testimony for trial: Trial Name: NCT05124522 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment for this experiment still available?
"Yes, according to the records on clinicaltrials.gov, this experiment is currently enrolling participants. This research was initially published on October 25th 2021 and last modified November 5th 2021; seeking 60 people across a single centre."
Answered by AI
What is the target enrollment of participants for this clinical trial?
"Affirmative. Clinicaltrials.gov records show that this clinical trial, which went live on October 25th 2021, is currently enrolling participants. The target recruitment volume is 60 individuals from a single site."
Answered by AI
Who else is applying?
What state do they live in?
Illinois
Colorado
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
Always interested in trials to help further help those with MS.
PatientReceived 1 prior treatment
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger